Oneness Biotech Co., Ltd. (TPEX: 4743)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
150.50
-4.50 (-2.90%)
Sep 10, 2024, 1:30 PM CST
-11.97%
Market Cap 71.81B
Revenue (ttm) 101.93M
Net Income (ttm) -978.89M
Shares Out 477.12M
EPS (ttm) -2.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,081,531
Open 155.50
Previous Close 155.00
Day's Range 149.00 - 156.50
52-Week Range 128.00 - 241.44
Beta 1.59
Analysts n/a
Price Target n/a
Earnings Date Nov 8, 2024

About Oneness Biotech

Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation segments. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials. It is also developing FB825, which is in Phase IIa clinical trial for treating atopic dermatitis and allergic asthma; FB704A that has co... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 43
Stock Exchange Taipei Exchange
Ticker Symbol 4743
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.